1-propanol has been researched along with lovastatin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castaño, G; Crespo, N; Fernández, J; Fernández, L; Illnait, J; Más, R | 1 |
| Más, R; Mesa, R; Noa, M | 1 |
| McCarty, MF | 1 |
| Castaño, G; Fernández, L; Gámez, R; Illnait, J; Más, R | 1 |
| Alvarez, E; Amor, A; Castaño, G; Fernández, JL; González, RL; Lezcay, M; Más, R; Menéndez, R | 1 |
| Carlomagno, G; Fazio, S; Mercurio, V; Pirozzi, C; Ruvolo, A | 1 |
| Battista, F; Bonaduce, D; Bosso, G; Brambilla, N; D'Amato, M; Fazio, V; Galletti, F; Gentile, M; Giacovelli, G; Mercurio, V; Pucci, G; Schillaci, G; Vitalini, C | 1 |
5 trial(s) available for 1-propanol and lovastatin
| Article | Year |
|---|---|
Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
Topics: Anticholesteremic Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Alcohols; Female; Headache; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Risk Factors; Treatment Outcome | 1999 |
Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Fatty Alcohols; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Lovastatin; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Severity of Illness Index; Time Factors; Walking | 2003 |
Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
Topics: Aged; Anticholesteremic Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Alcohols; Female; Humans; Hyperlipidemias; Lipid Metabolism; Lipid Peroxidation; Lipids; Lovastatin; Male; Middle Aged; Pilot Projects; Treatment Outcome | 2002 |
Effects of a nutraceutical combination on left ventricular remodeling and vasoreactivity in subjects with the metabolic syndrome.
Topics: Anticholesteremic Agents; Berberine; Cardiotonic Agents; Dietary Supplements; Fatty Alcohols; Female; Humans; Insulin Resistance; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Vasodilation; Ventricular Remodeling | 2012 |
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
Topics: Adult; Aged; Berberine; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Fatty Alcohols; Female; Humans; Hypertrophy, Left Ventricular; Insulin Resistance; Lipid Metabolism; Lovastatin; Male; Metabolic Syndrome; Middle Aged; Placebos; Treatment Outcome | 2019 |
2 other study(ies) available for 1-propanol and lovastatin
| Article | Year |
|---|---|
A comparative study of policosanol vs lovastatin on intimal thickening in rabbit cuffed carotid artery.
Topics: Animals; Anticholesteremic Agents; Carotid Arteries; Cell Division; Fatty Alcohols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Proliferating Cell Nuclear Antigen; Rabbits; Tunica Intima | 2001 |
Policosanol safely down-regulates HMG-CoA reductase - potential as a component of the Esselstyn regimen.
Topics: Animals; Cholesterol, LDL; Clinical Trials as Topic; Cohort Studies; Diet, Vegetarian; Dietary Fats; Dietary Supplements; Double-Blind Method; Drug Costs; Enzyme Activation; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lovastatin; Myocardial Infarction; Platelet Activation; Protein Prenylation; Protein Processing, Post-Translational; Rabbits; Rats; rho GTP-Binding Proteins; Safety | 2002 |